Vanguard Group’s Allergan Inc AGN Stock Holding History

Vanguard Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-16,101,385	Closed	-$3.42B	–	4227
2014 Q4	$3.42B	Buy	16,101,385 +157,536	+1%	+$31.3M	0.25%	76
2014 Q3	$2.84B	Buy	15,943,849 +764,192	+5%	+$127M	0.22%	83
2014 Q2	$2.57B	Buy	15,179,657 +203,196	+1%	+$31.6M	0.2%	92
2014 Q1	$1.86B	Buy	14,976,461 +456,284	+3%	+$55.6M	0.16%	123
2013 Q4	$1.61B	Buy	14,520,177 +274,878	+2%	+$26.3M	0.14%	139
2013 Q3	$1.29B	Buy	14,245,299 +10,788	+0.1%	+$968K	0.13%	150
2013 Q2	$1.2B	Buy	+14,234,511	New	+$1.48B	0.13%	143

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Vanguard Group's AGN Position: Q1 2015 in Review

Vanguard Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 16,101,385 shares — an estimated $3.42B sold.

Vanguard Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $3.42B in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Vanguard Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Vanguard Group sold 16,101,385 Allergan Inc shares in Q1 2015, an estimated $3.42B.
Vanguard Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Vanguard Group's Allergan Inc position peaked at $3.42B in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.